Valerio Therapeutics to Acquire Etherna Immunotherapies, Prices €40.25 Million PIPE

Acquirer: Valerio Therapeutics · Target: Etherna Immunotherapies · Deal Value: €30M Enterprise Value · Concurrent Financing: €40.25M PIPE · Date: August 24, 2026 Summary Valerio Therapeutics signed definitive agreements to acquire 100% of Etherna Immunotherapies at a €30 million enterprise value and priced a €40.25…